Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for VanEck Biotech ETF (BBH : NSDQ)
 
 • Company Description   
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $158.16 Daily Weekly Monthly
20 Day Moving Average: 8,980 shares
Shares Outstanding: 3.10 (millions)
Market Capitalization: $489.76 (millions)
Beta: 0.84
52 Week High: $170.25
52 Week Low: $131.12
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.05% 1.09%
12 Week -1.31% -4.33%
Year To Date -0.99% -4.63%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
-
-
-,- -
-
ph: -
fax: -
None None
 
 • General Corporate Information   
Officers
- - -
- - -
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: FIN-INVEST FUND
Sector: Finance
CUSIP: 92189F726
SIC: 6726
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 3.10
Most Recent Split Date: 2.00 (3.00:1)
Beta: 0.84
Market Capitalization: $489.76 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.47%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.75
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 12/19/2022 - $0.75
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
12/31/22 - -
09/30/22 - -
06/30/22 - -
ROA
12/31/22 - -
09/30/22 - -
06/30/22 - -
Current Ratio
12/31/22 - -
09/30/22 - -
06/30/22 - -
Quick Ratio
12/31/22 - -
09/30/22 - -
06/30/22 - -
Operating Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Net Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Pre-Tax Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Book Value
12/31/22 - -
09/30/22 - -
06/30/22 - -
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Capital
12/31/22 - -
09/30/22 - -
06/30/22 - -
 

Powered by Zacks Investment Research ©